Dry eye disease in the menopausal transition: toward recognition as a hormonal manifestation

Dry eye symptoms affect an estimated 64-80% of perimenopausal and postmenopausal women, placing dry eye disease (DED) among the most prevalent yet least recognized manifestations of the menopausal endocrine transition. The pathophysiology centers on androgen deficiency and altered estrogen signaling, with sex hormone receptors expressed throughout the ocular surface, and the 2025 Tear Film and Ocular Surface Society Dry Eye Workshop III recognizes sex, gender and hormones as one of seven major domains influencing DED. Objective ocular surface signs are significantly worse in postmenopausal compared with premenopausal women even when subjective symptoms are similar, mirroring the symptom-sign dissociation well recognized in genitourinary syndrome of menopause. This hormonally mediated dry eye is described in recent literature as menopausal dry eye. This opinion advocates for routine screening using the validated Ocular Surface Disease Index-6 questionnaire, counseling patients on the ocular implications of hormone therapy and timely referral to eye care providers for persistent or moderate-to-severe symptoms. Recognizing dry eye as a menopausal disease can improve how ocular symptoms are attributed, discussed and treated in midlife women.

Authors

Institutions

Publication Details

Journal
Climacteric
Published
2026-11-17
DOI
https://doi.org/10.1080/13697137.2026.2752791
Primary Topic
Ocular Surface and Contact Lens
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Dry eye disease in the menopausal transition: toward recognition as a hormonal manifestation

Zachary P. Skurski, James A. Simon, Anita Mikkilineni
1 links
Climacteric
Ocular Surface and Contact Lens
article

Dry eye disease in the menopausal transition: toward recognition as a hormonal manifestation

Zachary P. Skurski, James A. Simon, Anita Mikkilineni
article en

Abstract

Dry eye symptoms affect an estimated 64-80% of perimenopausal and postmenopausal women, placing dry eye disease (DED) among the most prevalent yet least recognized manifestations of the menopausal endocrine transition. The pathophysiology centers on androgen deficiency and altered estrogen signaling, with sex hormone receptors expressed throughout the ocular surface, and the 2025 Tear Film and Ocular Surface Society Dry Eye Workshop III recognizes sex, gender and hormones as one of seven major domains influencing DED. Objective ocular surface signs are significantly worse in postmenopausal compared with premenopausal women even when subjective symptoms are similar, mirroring the symptom-sign dissociation well recognized in genitourinary syndrome of menopause. This hormonally mediated dry eye is described in recent literature as menopausal dry eye. This opinion advocates for routine screening using the validated Ocular Surface Disease Index-6 questionnaire, counseling patients on the ocular implications of hormone therapy and timely referral to eye care providers for persistent or moderate-to-severe symptoms. Recognizing dry eye as a menopausal disease can improve how ocular symptoms are attributed, discussed and treated in midlife women.

Climacteric
Uniformed Services University of the Health Sciences (US), George Washington University (US)
Good health and well-being
Ocular Surface and Contact Lens
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon